Italia markets close in 5 hours 46 minutes

Coloplast A/S (CLPBF)

Other OTC - Other OTC Prezzo differito. Valuta in USD.
Aggiungi a watchlist
122,500,00 (0,00%)
Alla chiusura: 03:41PM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente122,50
Aperto122,50
Denaro0,00 x 0
Lettera0,00 x 0
Min-Max giorno122,50 - 122,50
Intervallo di 52 settimane99,78 - 145,05
Volume649
Media Volume308
Capitalizzazione28,782B
Beta (5 anni mensile)0,29
Rapporto PE (ttm)38,04
EPS (ttm)3,22
Prossima data utiliN/D
Rendimento e dividendo (futuro)3,04 (2,48%)
Data ex dividendo08 dic 2023
Stima target 1A13,57
  • GlobeNewswire

    Coloplast A/S - Financial Calendar 2023-24

    Please see enclosed pdf. For more information and calendar invitations for upcoming events, please visit: https://investor.coloplast.com/investor-relations/financial-calendar-and-events/ Kind regards,Investor RelationsColoplast A/STel. +45 4911 1800 For further information, please contact Investors and analystsAnders Lonning-SkovgaardExecutive Vice President, CFOTel. +45 4911 1111 Aleksandra DimovskaSenior Director, Investor RelationsTel. +45 4911 1800 / +45 4911 2458Email: dkadim@coloplast.com

  • GlobeNewswire

    Coloplast A/S - Coloplast completes the acquisition of Kerecis - Invitation for conference call on Monday, 4 September 2023 at 14.00-15.00 CEST

    Monday, 4 September 2023 at 14.00 – 15.00 CESTIn connection with the completion of the acquisition of Kerecis, Coloplast will host a conference call with Fertram Sigurjonsson, Founder and CEO of Kerecis.A presentation will be available on Coloplast’s website before the conference call. The webcast of the conference call will be available during and after the event. Coloplast will be represented by:Kristian Villumsen - President & CEOAnders Lonning-Skovgaard - Executive Vice President, CFOFertram

  • GlobeNewswire

    Coloplast A/S - Announcement no. 08/2023 - Coloplast announces registration of share capital increase of 12.2 new B shares completed

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR AUSTRALIA, EXCEPT AS PERMITTED BY APPLICABLE LAW, OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL. Coloplast announces registration of share capital increase of 12.2 new B shares completed Coloplast A/S (“Coloplast”) has in connection with the directed issue and private placement to